CAR-expressing T cells demonstrate impressive response rates hematological malignancies, but mediate limited anti-tumor efficacy in solid tumors. The T cell exhaustion-mediated dysfunction is an important barrier to progress, which raises the prospect that engineering exhaustion-resistant CAR-T cells could improve clinical outcomes. Learn more, https://www.creative-biola...